SC 13G Filing

Company

PUMA BIOTECHNOLOGY, INC.

Filed

March 26, 2020

Accession Number

0000935836-20-000215

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →